Eleison Pharmaceuticals Competitors and Similar CompaniesClear all

Eleison Pharmaceuticals's competitors and similar companies include StemMed, Exelixis and Halozyme Therapeutics.

	Eleison Pharmaceuticals Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.	StemMed StemMed is a pharmaceutical development and testing company that provides pre-clinical drug testing services using a panel of patient-derived xenograft (PDX) models of breast and pancreatic cancers.	Exelixis Exelixis is an oncology company that develops cancer treatments.	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Founding Date	Founding Date 2008	Founding Date 2009	Founding Date 1994	Founding Date 1998
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Princeton, US HQ	Locations Houston, US HQ	Locations Alameda, US HQ	Locations San Diego, US HQ
Employees	Employees 12	Employees 2	Employees 1,14712% decrease	Employees 373157% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 8.2 b	Valuation ($) 6.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.3b (FY, 2025)	Revenue (est.) $1.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $83.7m (FY, 2025)	Cost of goods $228.8m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $2.2b (FY, 2025)	Gross profit $1.2b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $782.6m (FY, 2025)	Net income $316.9m (FY, 2025)

For sources of this data, please see the company profile

View Company Profiles

StemMed

Houston, US

Employees

StemMed is a pharmaceutical development and testing company that provides pre-clinical drug testing services using a panel of patient-derived xenograft (PDX) models of breast and pancreatic cancers.

View company

Exelixis

Alameda, US

Employees

1,147↓ 12% decrease

Exelixis is an oncology company that develops cancer treatments.

View company

Halozyme Therapeutics

San Diego, US

Employees

373

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.